Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock Holdings Decreased by Diversify Advisory Services LLC

Diversify Advisory Services LLC lowered its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 20.8% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,977 shares of the company’s stock after selling 780 shares during the period. Diversify Advisory Services LLC’s holdings in Ryan Specialty were worth $203,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Capstone Investment Advisors LLC bought a new stake in shares of Ryan Specialty during the 1st quarter valued at about $727,000. Securian Asset Management Inc. bought a new stake in shares of Ryan Specialty during the 2nd quarter valued at about $474,000. Embree Financial Group bought a new stake in shares of Ryan Specialty during the 1st quarter valued at about $1,701,000. Geneva Capital Management LLC grew its position in shares of Ryan Specialty by 12.0% during the 1st quarter. Geneva Capital Management LLC now owns 475,552 shares of the company’s stock valued at $26,393,000 after buying an additional 50,947 shares during the last quarter. Finally, Xponance Inc. grew its position in shares of Ryan Specialty by 67.2% during the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after buying an additional 8,312 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.3 %

Shares of NYSE:RYAN opened at $66.71 on Friday. The stock has a market capitalization of $17.44 billion, a price-to-earnings ratio of 86.64, a PEG ratio of 1.56 and a beta of 0.62. The company has a 50 day moving average price of $67.04 and a 200 day moving average price of $60.41. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.09 and a current ratio of 1.09. Ryan Specialty Holdings, Inc. has a 1-year low of $41.49 and a 1-year high of $73.10.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 48.99%. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 EPS. On average, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.81 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty’s payout ratio is presently 57.14%.

Analyst Upgrades and Downgrades

RYAN has been the subject of a number of recent research reports. Barclays initiated coverage on shares of Ryan Specialty in a research report on Wednesday, September 4th. They set an “overweight” rating and a $76.00 price objective for the company. Bank of America boosted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. UBS Group boosted their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. Wells Fargo & Company boosted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Finally, Citigroup boosted their target price on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty has an average rating of “Hold” and a consensus target price of $70.33.

Insider Activity at Ryan Specialty

In related news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the firm’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $65.18, for a total value of $1,709,866.94. Following the transaction, the executive vice president now directly owns 24,845 shares in the company, valued at approximately $1,619,397.10. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total value of $347,923.75. Following the sale, the director now directly owns 2,685 shares in the company, valued at $173,800.05. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the firm’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the completion of the sale, the executive vice president now owns 24,845 shares in the company, valued at $1,619,397.10. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 2,107,136 shares of company stock worth $131,860,032. 11.10% of the stock is owned by insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.